Market Indices
Sector Heatmap
ABBV — ABBVIE INC.
NYSEABBVIE INC.
- O
- 260.51
- H
- 262.32
- L
- 259.00
- V
- 3.77M
ABBV — Latest News & Headlines
20 StoriesAbbVie (ABBV) Stock May Be 41% Undervalued Following JUVMO Approval - Yahoo Finance
AbbVie (ABBV) Stock May Be 41% Undervalued Following JUVMO Approval Yahoo Finance
AbbVie (ABBV) Stock May Be 41% Undervalued Following Migraine Trial Win - Simply Wall Street
AbbVie (ABBV) Stock May Be 41% Undervalued Following Migraine Trial Win Simply Wall Street
If You Invested $1000 In AbbVie Stock 10 Years Ago, You Would Have This Much Today - Benzinga
If You Invested $1000 In AbbVie Stock 10 Years Ago, You Would Have This Much Today Benzinga
ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell? - theglobeandmail.com
ABBV Stock Rises 25% in 6 Months: Time to Buy, Hold or Sell? theglobeandmail.com
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade - The Motley Fool
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade The Motley Fool
AbbVie’s oral arthritis drug approved in EU for children as young as 2 - stocktitan.net
AbbVie’s oral arthritis drug approved in EU for children as young as 2 stocktitan.net
AbbVie Inc (ABBV) Stock Down 1.1% but Still Overvalued -- GF Sco - GuruFocus
AbbVie Inc (ABBV) Stock Down 1.1% but Still Overvalued -- GF Sco GuruFocus
AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval - Simply Wall Street
AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval Simply Wall Street
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
AbbVie (ABBV) Wins A New Lymphoma Nod, Is The Stock Still Cheap? - Simply Wall Street
AbbVie (ABBV) Wins A New Lymphoma Nod, Is The Stock Still Cheap? Simply Wall Street
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance UK
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Yahoo Finance UK
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV) - Yahoo Finance
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV) Yahoo Finance
Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's? - Yahoo Finance
Is AbbVie (ABBV) A Bargain After FDA Approval Of JUVMO For Parkinson's? Yahoo Finance
Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick? - Yahoo Finance
Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick? Yahoo Finance
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? - Yahoo Finance
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026? Yahoo Finance
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note Yahoo Finance
At 16 weeks, all three doses of AbbVie’s eczema treatment improved skin more than placebo. - stocktitan.net
At 16 weeks, all three doses of AbbVie’s eczema treatment improved skin more than placebo. stocktitan.net
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo! Finance Canada
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know Yahoo! Finance Canada
2026 2H Healthcare Dividend Roundup: Johnson & Johnson Outshines AbbVie (NYSE:ABBV) - Seeking Alpha
2026 2H Healthcare Dividend Roundup: Johnson & Johnson Outshines AbbVie (NYSE:ABBV) Seeking Alpha